A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session7245fe87f1e87127e9ad1bc6e95e738500d04bb1): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Shingles Treatments Market Research Report 2024

img

Global Shingles Treatments Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Shingles Treatments Market Research Report 2024

Shingles is a viral disease characterized by a painful skin rash with blisters in a localized area.
According to MRAResearch’s new survey, global Shingles Treatments market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Shingles Treatments market research.
The shingles treatment market is expected to witness a high growth over the forecast period owing to the increasing prevalence of shingles.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Shingles Treatments market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Astellas Pharma
Foamix
Novartis
Roche
GlaxoSmithKline
Epiphany Biosciences
Merck
Beijing Minhai Biotechnology
GeneOne Life Science
NAL Pharmaceuticals
TSRL
Segment by Type
Oral
Tablets

Segment by Application


Clinics
Hospitals
Diagnostic Centres
Home Care Settings
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Shingles Treatments report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Shingles Treatments Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Oral
1.2.3 Tablets
1.3 Market by Application
1.3.1 Global Shingles Treatments Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Diagnostic Centres
1.3.5 Home Care Settings
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Shingles Treatments Market Perspective (2018-2033)
2.2 Shingles Treatments Growth Trends by Region
2.2.1 Global Shingles Treatments Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Shingles Treatments Historic Market Size by Region (2018-2023)
2.2.3 Shingles Treatments Forecasted Market Size by Region (2024-2033)
2.3 Shingles Treatments Market Dynamics
2.3.1 Shingles Treatments Industry Trends
2.3.2 Shingles Treatments Market Drivers
2.3.3 Shingles Treatments Market Challenges
2.3.4 Shingles Treatments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Shingles Treatments Players by Revenue
3.1.1 Global Top Shingles Treatments Players by Revenue (2018-2023)
3.1.2 Global Shingles Treatments Revenue Market Share by Players (2018-2023)
3.2 Global Shingles Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Shingles Treatments Revenue
3.4 Global Shingles Treatments Market Concentration Ratio
3.4.1 Global Shingles Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Shingles Treatments Revenue in 2022
3.5 Shingles Treatments Key Players Head office and Area Served
3.6 Key Players Shingles Treatments Product Solution and Service
3.7 Date of Enter into Shingles Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Shingles Treatments Breakdown Data by Type
4.1 Global Shingles Treatments Historic Market Size by Type (2018-2023)
4.2 Global Shingles Treatments Forecasted Market Size by Type (2024-2033)
5 Shingles Treatments Breakdown Data by Application
5.1 Global Shingles Treatments Historic Market Size by Application (2018-2023)
5.2 Global Shingles Treatments Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Shingles Treatments Market Size (2018-2033)
6.2 North America Shingles Treatments Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Shingles Treatments Market Size by Country (2018-2023)
6.4 North America Shingles Treatments Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Shingles Treatments Market Size (2018-2033)
7.2 Europe Shingles Treatments Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Shingles Treatments Market Size by Country (2018-2023)
7.4 Europe Shingles Treatments Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Shingles Treatments Market Size (2018-2033)
8.2 Asia-Pacific Shingles Treatments Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Shingles Treatments Market Size by Region (2018-2023)
8.4 Asia-Pacific Shingles Treatments Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Shingles Treatments Market Size (2018-2033)
9.2 Latin America Shingles Treatments Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Shingles Treatments Market Size by Country (2018-2023)
9.4 Latin America Shingles Treatments Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Shingles Treatments Market Size (2018-2033)
10.2 Middle East & Africa Shingles Treatments Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Shingles Treatments Market Size by Country (2018-2023)
10.4 Middle East & Africa Shingles Treatments Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Detail
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Shingles Treatments Introduction
11.1.4 Astellas Pharma Revenue in Shingles Treatments Business (2018-2023)
11.1.5 Astellas Pharma Recent Development
11.2 Foamix
11.2.1 Foamix Company Detail
11.2.2 Foamix Business Overview
11.2.3 Foamix Shingles Treatments Introduction
11.2.4 Foamix Revenue in Shingles Treatments Business (2018-2023)
11.2.5 Foamix Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Shingles Treatments Introduction
11.3.4 Novartis Revenue in Shingles Treatments Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Shingles Treatments Introduction
11.4.4 Roche Revenue in Shingles Treatments Business (2018-2023)
11.4.5 Roche Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Shingles Treatments Introduction
11.5.4 GlaxoSmithKline Revenue in Shingles Treatments Business (2018-2023)
11.5.5 GlaxoSmithKline Recent Development
11.6 Epiphany Biosciences
11.6.1 Epiphany Biosciences Company Detail
11.6.2 Epiphany Biosciences Business Overview
11.6.3 Epiphany Biosciences Shingles Treatments Introduction
11.6.4 Epiphany Biosciences Revenue in Shingles Treatments Business (2018-2023)
11.6.5 Epiphany Biosciences Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Shingles Treatments Introduction
11.7.4 Merck Revenue in Shingles Treatments Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Beijing Minhai Biotechnology
11.8.1 Beijing Minhai Biotechnology Company Detail
11.8.2 Beijing Minhai Biotechnology Business Overview
11.8.3 Beijing Minhai Biotechnology Shingles Treatments Introduction
11.8.4 Beijing Minhai Biotechnology Revenue in Shingles Treatments Business (2018-2023)
11.8.5 Beijing Minhai Biotechnology Recent Development
11.9 GeneOne Life Science
11.9.1 GeneOne Life Science Company Detail
11.9.2 GeneOne Life Science Business Overview
11.9.3 GeneOne Life Science Shingles Treatments Introduction
11.9.4 GeneOne Life Science Revenue in Shingles Treatments Business (2018-2023)
11.9.5 GeneOne Life Science Recent Development
11.10 NAL Pharmaceuticals
11.10.1 NAL Pharmaceuticals Company Detail
11.10.2 NAL Pharmaceuticals Business Overview
11.10.3 NAL Pharmaceuticals Shingles Treatments Introduction
11.10.4 NAL Pharmaceuticals Revenue in Shingles Treatments Business (2018-2023)
11.10.5 NAL Pharmaceuticals Recent Development
11.11 TSRL
11.11.1 TSRL Company Detail
11.11.2 TSRL Business Overview
11.11.3 TSRL Shingles Treatments Introduction
11.11.4 TSRL Revenue in Shingles Treatments Business (2018-2023)
11.11.5 TSRL Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Shingles Treatments Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Oral
Table 3. Key Players of Tablets
Table 4. Global Shingles Treatments Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Shingles Treatments Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Shingles Treatments Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Shingles Treatments Market Share by Region (2018-2023)
Table 8. Global Shingles Treatments Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Shingles Treatments Market Share by Region (2024-2033)
Table 10. Shingles Treatments Market Trends
Table 11. Shingles Treatments Market Drivers
Table 12. Shingles Treatments Market Challenges
Table 13. Shingles Treatments Market Restraints
Table 14. Global Shingles Treatments Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Shingles Treatments Market Share by Players (2018-2023)
Table 16. Global Top Shingles Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Shingles Treatments as of 2022)
Table 17. Ranking of Global Top Shingles Treatments Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Shingles Treatments Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Shingles Treatments Product Solution and Service
Table 21. Date of Enter into Shingles Treatments Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Shingles Treatments Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Shingles Treatments Revenue Market Share by Type (2018-2023)
Table 25. Global Shingles Treatments Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Shingles Treatments Revenue Market Share by Type (2024-2033)
Table 27. Global Shingles Treatments Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Shingles Treatments Revenue Market Share by Application (2018-2023)
Table 29. Global Shingles Treatments Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Shingles Treatments Revenue Market Share by Application (2024-2033)
Table 31. North America Shingles Treatments Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Shingles Treatments Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Shingles Treatments Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Shingles Treatments Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Shingles Treatments Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Shingles Treatments Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Shingles Treatments Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Shingles Treatments Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Shingles Treatments Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Shingles Treatments Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Shingles Treatments Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Shingles Treatments Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Shingles Treatments Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Shingles Treatments Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Shingles Treatments Market Size by Country (2024-2033) & (US$ Million)
Table 46. Astellas Pharma Company Detail
Table 47. Astellas Pharma Business Overview
Table 48. Astellas Pharma Shingles Treatments Product
Table 49. Astellas Pharma Revenue in Shingles Treatments Business (2018-2023) & (US$ Million)
Table 50. Astellas Pharma Recent Development
Table 51. Foamix Company Detail
Table 52. Foamix Business Overview
Table 53. Foamix Shingles Treatments Product
Table 54. Foamix Revenue in Shingles Treatments Business (2018-2023) & (US$ Million)
Table 55. Foamix Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis Shingles Treatments Product
Table 59. Novartis Revenue in Shingles Treatments Business (2018-2023) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Roche Company Detail
Table 62. Roche Business Overview
Table 63. Roche Shingles Treatments Product
Table 64. Roche Revenue in Shingles Treatments Business (2018-2023) & (US$ Million)
Table 65. Roche Recent Development
Table 66. GlaxoSmithKline Company Detail
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Shingles Treatments Product
Table 69. GlaxoSmithKline Revenue in Shingles Treatments Business (2018-2023) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Epiphany Biosciences Company Detail
Table 72. Epiphany Biosciences Business Overview
Table 73. Epiphany Biosciences Shingles Treatments Product
Table 74. Epiphany Biosciences Revenue in Shingles Treatments Business (2018-2023) & (US$ Million)
Table 75. Epiphany Biosciences Recent Development
Table 76. Merck Company Detail
Table 77. Merck Business Overview
Table 78. Merck Shingles Treatments Product
Table 79. Merck Revenue in Shingles Treatments Business (2018-2023) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Beijing Minhai Biotechnology Company Detail
Table 82. Beijing Minhai Biotechnology Business Overview
Table 83. Beijing Minhai Biotechnology Shingles Treatments Product
Table 84. Beijing Minhai Biotechnology Revenue in Shingles Treatments Business (2018-2023) & (US$ Million)
Table 85. Beijing Minhai Biotechnology Recent Development
Table 86. GeneOne Life Science Company Detail
Table 87. GeneOne Life Science Business Overview
Table 88. GeneOne Life Science Shingles Treatments Product
Table 89. GeneOne Life Science Revenue in Shingles Treatments Business (2018-2023) & (US$ Million)
Table 90. GeneOne Life Science Recent Development
Table 91. NAL Pharmaceuticals Company Detail
Table 92. NAL Pharmaceuticals Business Overview
Table 93. NAL Pharmaceuticals Shingles Treatments Product
Table 94. NAL Pharmaceuticals Revenue in Shingles Treatments Business (2018-2023) & (US$ Million)
Table 95. NAL Pharmaceuticals Recent Development
Table 96. TSRL Company Detail
Table 97. TSRL Business Overview
Table 98. TSRL Shingles Treatments Product
Table 99. TSRL Revenue in Shingles Treatments Business (2018-2023) & (US$ Million)
Table 100. TSRL Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Shingles Treatments Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Shingles Treatments Market Share by Type: 2022 VS 2033
Figure 3. Oral Features
Figure 4. Tablets Features
Figure 5. Global Shingles Treatments Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Shingles Treatments Market Share by Application: 2022 VS 2033
Figure 7. Clinics Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Diagnostic Centres Case Studies
Figure 10. Home Care Settings Case Studies
Figure 11. Shingles Treatments Report Years Considered
Figure 12. Global Shingles Treatments Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Shingles Treatments Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Shingles Treatments Market Share by Region: 2022 VS 2033
Figure 15. Global Shingles Treatments Market Share by Players in 2022
Figure 16. Global Top Shingles Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Shingles Treatments as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Shingles Treatments Revenue in 2022
Figure 18. North America Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Shingles Treatments Market Share by Country (2018-2033)
Figure 20. United States Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Shingles Treatments Market Share by Country (2018-2033)
Figure 24. Germany Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Shingles Treatments Market Share by Region (2018-2033)
Figure 32. China Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Shingles Treatments Market Share by Country (2018-2033)
Figure 40. Mexico Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Shingles Treatments Market Share by Country (2018-2033)
Figure 44. Turkey Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Shingles Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Astellas Pharma Revenue Growth Rate in Shingles Treatments Business (2018-2023)
Figure 47. Foamix Revenue Growth Rate in Shingles Treatments Business (2018-2023)
Figure 48. Novartis Revenue Growth Rate in Shingles Treatments Business (2018-2023)
Figure 49. Roche Revenue Growth Rate in Shingles Treatments Business (2018-2023)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Shingles Treatments Business (2018-2023)
Figure 51. Epiphany Biosciences Revenue Growth Rate in Shingles Treatments Business (2018-2023)
Figure 52. Merck Revenue Growth Rate in Shingles Treatments Business (2018-2023)
Figure 53. Beijing Minhai Biotechnology Revenue Growth Rate in Shingles Treatments Business (2018-2023)
Figure 54. GeneOne Life Science Revenue Growth Rate in Shingles Treatments Business (2018-2023)
Figure 55. NAL Pharmaceuticals Revenue Growth Rate in Shingles Treatments Business (2018-2023)
Figure 56. TSRL Revenue Growth Rate in Shingles Treatments Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed